Uncommon toxicity of low-dose methotrexate: case report
Background: Standard treatment of Gestational Trophoblastic Disease (GTD) is chemotherapy. Single-agent chemotherapy regime including Methotrexate (MTX) or Actinomycin. Single-agent is widely used in treatment of persistent trophoblastic disease. We reported an uncommon toxicity of low-dose single-a...
Main Authors: | Zohreh Yousefi, Golrokh Sherafati, Azar Fani |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2015-10-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5378&slc_lang=en&sid=1 |
Similar Items
-
Uncommon presentation of methotrexate-induced toxic erythema of chemotherapy
by: Preema Sinha, et al.
Published: (2021-01-01) -
Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
by: Tu X, et al.
Published: (2020-06-01) -
A case of Severe Low-dose Methotrexate-induced Toxicity
by: Filiz Topaloğlu Demir, et al.
Published: (2016-12-01) -
Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report
by: Rainer Ullrich Pliquett, et al.
Published: (2020-02-01) -
Successful treatment of gestational trophoblastic neoplasia in the uterine cornus with laparoscopic cornuostomy and postoperative methotrexate injection
by: Pei-Ling Chen, et al.
Published: (2017-04-01)